2022-2023 Interim Flu Vaccine Effectiveness (VE) Results
Reference this summary to review interim VE results for the 2022-2023 influenza season. Early estimates from 2 concurrent studies indicate a substantially reduced risk of medically attended influenza in vaccinated persons aged < 65 years and symptomatic influenza in vaccinated children and adolescents.
Download
Resource Notes:

- Provides a QR code to access the full interim results as well as study design and limitations in the Morbidity and Mortality Weekly Report (MMWR)
- Outlines positive VE outcomes against influenza in children and adults
- Highlights the importance of influenza vaccination as noted by the CDC